Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/14398
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNewcombe, D.en
dc.contributor.authorBochner, F.en
dc.contributor.authorWhite, J.en
dc.contributor.authorSomogyi, A.en
dc.date.issued2004en
dc.identifier.citationDrug and Alcohol Dependence, 2004; 76(1):63-72en
dc.identifier.issn0376-8716en
dc.identifier.issn1879-0046en
dc.identifier.urihttp://hdl.handle.net/2440/14398-
dc.description.abstractThe aim of this study was to determine if substitution of daily methadone with second daily levo-alpha-acetylmethadol (LAAM) would convert non-holders on methadone into holders on LAAM, and to compare plasma concentration–time profiles of (R)-methadone with LAAM and its two metabolites. Sixteen stable methadone maintenance treatment participants (non-holders, n=8) were randomly allocated to continue methadone for 3 months or switch to LAAM for 3 months, and then crossed over to the alternative drug for 3 months. At steady state, there were two testing sessions (24 h for methadone and 48 h for LAAM), during which opioid withdrawal severity, respiration rate and pupil diameter were measured 10–11 times and venous blood was collected 13–15 times. Ten age- and gender-matched controls underwent one 48-h test session. Areas under the withdrawal severity score versus time curve (AUC0–47 hours for LAAM and controls; AUC0–24 × 2 for methadone) were similar in holders on methadone and LAAM (P=0.62), but were greater in non-holders when they were taking methadone than LAAM (P<0.001). Respiratory depression and pupillary constriction were similar for LAAM and methadone. In comparison to (R)-methadone, plasma nor- and dinor-LAAM concentrations fluctuated little over the dosing interval. LAAM converted methadone non-holders into LAAM holders. LAAM may therefore be useful in selected MMT non-holders and improve retention in opioid treatment programs.en
dc.description.statementofresponsibilityDavid A. L. Newcombe, Felix Bochner, Jason M. White and Andrew A. Somogyien
dc.description.urihttp://www.elsevier.com/wps/find/journaldescription.cws_home/506052/description#descriptionen
dc.language.isoenen
dc.publisherElsevier Sci Ireland Ltden
dc.subjectMethadone; LAAM; holders; non-holders; pharmacokinetics; pharmacodynamicsen
dc.titleEvaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysisen
dc.typeJournal articleen
dc.identifier.rmid0020041502en
dc.identifier.doi10.1016/j.drugalcdep.2004.04.004en
dc.identifier.pubid56257-
pubs.library.collectionPharmacology publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidSomogyi, A. [0000-0003-4779-0380]en
Appears in Collections:Pharmacology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.